Please note: Forest Laboratories, Inc. is not responsible for
the content or services on the site you will now visit.
TEFLARO® ABSSSI trials involved a range of complicated
cases, including S. aureus bacteremia
These hypothetical case studies present examples of types of patients who may benefit from TEFLARO.
Vancomycin plus aztreonam — 1g vancomycin administered IV over 1 hour followed by 1g aztreonam administered IV over 1 hour every 12 hours for 5-14 days
— Major abscess with ≥5 cm of surrounding erythema
— Wound infection
— Deep/extensive cellulitis
NOTE: BMI, body mass index (calculated as the weight in kilograms divided by the square of
height in meters); SD, standard deviation.
*Includes patients with surgical procedures performed <24 hours before first dose or randomization and <48 hours after first dose.
Adapted from Corey GR et al. Clin Infect Dis. 2010. Reproduced with permission of the Infectious Diseases Society of America.